Key result
miR-17-3p agomir promotes cardiomyocyte survival and protects against adverse remodeling after ischemia/reperfusion injury in mice.
Answers are grounded in this paper and cite their sources.
Limited microRNAs (miRNAs, miRs) have been reported to be necessary for exercise-induced cardiac growth and essential for protection against pathological cardiac remodeling. Here we determined members of the miR-17-92 cluster and their passenger miRNAs expressions in two distinct murine exercise models and found that miR-17-3p was increased in both. miR-17-3p promoted cardiomyocyte hypertrophy, proliferation, and survival. TIMP-3 was identified as a direct target gene of miR-17-3p whereas PTEN was indirectly inhibited by miR-17-3p. Inhibition of miR-17-3p in vivo attenuated exercise-induced cardiac growth including cardiomyocyte hypertrophy and expression of markers of myocyte proliferation. Importantly, mice injected with miR-17-3p agomir were protected from adverse remodeling after cardiac ischemia/reperfusion injury. Collectively, these data suggest that miR-17-3p contributes to exercise-induced cardiac growth and protects against adverse ventricular remodeling. miR-17-3p may represent a novel therapeutic target to promote functional recovery after cardiac ischemia/reperfusion.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2017) studied Myocardial ischemia-reperfusion injury and exercise-induced cardiac growth. miR-17-3p agomir or inhibition vs. Control was evaluated on Cardiac growth, cardiomyocyte hypertrophy, proliferation, and survival, and adverse remodeling after ischemia/reperfusion. In mice, miR-17-3p promoted cardiomyocyte hypertrophy and survival, and treatment with miR-17-3p agomir protected against adverse remodeling after cardiac ischemia/reperfusion injury.
Synapse has enriched 10 related papers. Consider them for comparative context: